Antiangiogenesis for cancer therapy.
Harris
A L
AL
Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. aharris@icrf.icnet.uk
D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors*; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000503:physiopathology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000503:physiopathology / Q000628:therapy; D009389:Neovascularization, Pathologic / Q000517:prevention & control / Q000628:therapy*; D011379:Prognosis
D043925:Angiogenesis Inducing Agents